SCHEMBL1314092

SCHEMBL1314092

OC(Cl)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705554 0.72
Dibromochloromethane SCHEMBL76438 0.72
Bromodichloromethane SCHEMBL75683 0.72
SCHEMBL95260 0.72
SCHEMBL23396 0.72
SCHEMBL4810225 0.71
SCHEMBL20448722 0.69
SCHEMBL11274911 0.67
Water SCHEMBL3326761 0.67 LMNA (0.38)
Bromodichloromethane SCHEMBL20771573 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273726-B2 Compositions for treating and/or preventing diseases characterized by the presence of metal ions BRANDEIS UNIVERSITY (US) 2012-09-25 US disclosed
US-20110275703-A1 SUBSTITUTED SPIROKETAL DERIVATIVES AND USE THEREOF AS THERAPEUTIC DRUG FOR DIABETES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2011-11-10 US disclosed
US-20100184724-A1 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS GRENPHARMA LLC (US) 2010-07-22 US disclosed
US-7595308-B2 Treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using organosilicon compounds such as dichlorodiethylsilane GRENPHARMA LLC (US) 2009-09-29 US disclosed
US-20090203644-A1 Compositions for treating and/or preventing diseases characterized by the presence of metal ions GRENPHARMA LLC (US) 2009-08-13 US disclosed
EP-2048153-A1 SUBSTITUTED SPIROKETAL DERIVATIVE AND USE THEREOF AS DRUG FOR TREATING DIABETES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-04-15 EP disclosed
EP-1583765-A4 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS GRENPHARMA LLC (US) 2008-03-26 EP disclosed
EP-1812013-A1 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF THE METAL IONS Grenpharma LLC (US) 2007-08-01 EP disclosed
WO-2006047477-A1 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF THE METAL IONS GRENPHARAMA LLC (US) 2006-05-04 WO disclosed
US-20060040897-A1 Compositions for treating and/or preventing diseases characterized by the presence of metal ions GRENPHARMA, LLC 2006-02-23 US disclosed
EP-1583765-A2 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS Grenpharma LLC (US) 2005-10-12 EP disclosed
WO-2004045552-A2 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS GRENPHARMA LLC (US) 2004-06-03 WO disclosed
US-5466710-A Heterobicycloalkanes as pesticidal compounds ROUSSEL UCLAF (FR) 1995-11-14 US disclosed
US-5039693-A Pyrazole amides and insecticide and miticide containing them as active ingredient MITSUBISHI KASEI CORPORATION (JP) 1991-08-13 US disclosed
EP-0365925-A1 Pyrazole amides and insecticide and miticide containing them as active ingredient Mitsubishi Chemical Corporation (JP) 1990-05-02 EP disclosed